{{Rsnum
|rsid=2152324
|Gene=NALCN
|Chromosome=13
|position=101417809
|Orientation=plus
|GMAF=0.1566
|Gene_s=NALCN
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 67.3 | 31.9 | 0.9
| HCB | 64.7 | 29.4 | 5.9
| JPT | 69.9 | 26.5 | 3.5
| YRI | 98.0 | 2.0 | 0.0
| ASW | 91.2 | 8.8 | 0.0
| CHB | 64.7 | 29.4 | 5.9
| CHD | 56.0 | 36.7 | 7.3
| GIH | 85.1 | 13.9 | 1.0
| LWK | 89.8 | 10.2 | 0.0
| MEX | 36.2 | 50.0 | 13.8
| MKK | 94.2 | 5.1 | 0.6
| TSI | 72.3 | 25.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23047292
|Title=Analysis of treatment-resistant schizophrenia and 384 markers from candidate genes
}}

{{on chip | Affy GenomeWide 6}}